Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Myasthenia Gravis × Population Groups × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 1 Neuromuscular Diseases 1 Neoplasms 1 Myasthenia Gravis 1 Breast Neoplasms 1 Autoimmune Diseases 1

Interventions

telitacicept 3 rozanolixizumab 2 Prednisone 2 ravulizumab 1 fludarabine 1 blinatumomab 1 Pyridostigmine Bromide 1 Psychodrama 1 Prednisolone 1 Population Groups 1 Cyclophosphamide 1 Art Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06827587 2025-02-14

Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis

First Affiliated Hospital of Wenzhou Medical University

Phase NA Not yet recruiting

Autoimmune Diseases, Myasthenia Gravis, Neuromuscular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡